US FDA warns Singapore maker of Tiger Balm products

Reuters, 12 Aug 2010
Singapore-based Haw Par Corporation Ltd, the maker of Tiger Balm, failed to adequately test its healthcare unit's over-the-counter products, the U.S. drug regulator said in a warning letter made public on Tuesday.
The company's subsidiary, Haw Par Healthcare Ltd, misbranded its Tiger Balm pain-relieving patch, which qualifies as a drug and must be approved, the regulator said. Full Story

Related:
FDA warns Singapore maker of Tiger Balm products - MSNBC.com
FDA warns Singapore maker of Tiger Balm products - Tehran Times